\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ demonstrated\\ an\\ elderly\\ male\\ who\\ was\\ alert\\ and\\ oriented\\ times\\ two\\.\\ \\ patient\\ did\\ not\\ have\\ slurred\\ speech\\ or\\ weakness\\.\\ \\ laboratory\\ work\\ was\\ unremarkable\\.\ \(0\)\
\-\ this\\ was\\ an\\ incidental\\ finding\\ and\\ no\\ treatment\\ or\\ follow\\ up\\ is\\ necessary\\ unless\\ patient\\ symptomatology\\ changes\\.\ \(0\)\
\-\ an\\ axial\\ ct\\ through\\ the\\ brain\\ demonstrates\\ a\\ rounded\\ soft\\ tissue\\ mass\\ adherent\\ to\\ the\\ anterior\\ falx\\ on\\ the\\ right\\.\\ \\ the\\ mass\\ appears\\ to\\ contain\\ some\\ calcification\\ centrally\\.\\ \\ on\\ post\\ contrast\\ images\\,\\ this\\ mass\\ strongly\\ and\\ homogenously\\ enhances\\.\\ \\ \\ the\\ remaining\\ evaluation\\ of\\ the\\ brain\\ is\\ unremarkable\\ with\\ preservation\\ of\\ grey\\-white\\ matter\\ differentiation\\ throughout\\.\\ \\ no\\ hyperdenities\\ were\\ seen\\ to\\ suggest\\ acute\\ hemorrhage\\.\ \(0\)\
\-\ meningioma\ \(167\)\
\-\ meningioma\ \(167\)\
\-\ dermoid\ \(313\)\
\-\ 88\\-year\\ old\\ male\\ presents\\ to\\ the\\ emergency\\ room\\ with\\ one\\-day\\ history\\ of\\ mental\\ status\\ changes\\,\\ per\\ patient\\ caregiver\\.\ \(1\)\
\-\ meningiomas\\ are\\ well\\-defined\\ extra\\-axial\\ masses\\ with\\ a\\ peak\\ incidence\\ in\\ patients\\ 40\\-60\\ years\\ of\\ age\\.\\ \\ this\\ was\\ an\\ incidental\\ finding\\ in\\ this\\ patient\\,\\ imaged\\ for\\ stroke\\ evaluation\\.\\ \\ the\\ female\\ to\\ male\\ ratio\\ is\\ 2\\:1\\.\\ \\ these\\ are\\ the\\ most\\ common\\ nonglial\\ intracranial\\ tumor\\.\\ \\ meningiomas\\ are\\ predominantly\\ benign\\ with\\ malignant\\ meningiomas\\ being\\ exceedingly\\ rare\\.\ \(0\)\
\-\ on\\ ct\\ images\\,\\ meningiomas\\ can\\ be\\ isodense\\ with\\ brain\\,\\ homogenously\\ hyperdense\\,\\ or\\ variably\\ calcified\\.\\ \\ this\\ case\\ demonstrates\\ central\\ stippled\\ calcification\\.\\ \\ they\\ typically\\ enhance\\ strongly\\ post\\ contrast\\ administration\\,\\ as\\ in\\ this\\ case\\.\\ \\ 60\\%\\ of\\ tumors\\ will\\ demontrate\\ a\\ dural\\ tail\\ on\\ mri\\ imaging\\,\\ which\\ represents\\ either\\ the\\ tumor\\ itself\\ or\\ underlying\\ dural\\ reaction\\.\\ \\ this\\ is\\ not\\ specific\\ for\\ meningiomas\\,\\ however\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ meningiomas\\:\\ 0\\.10841810550394285\ \(0\)\
\-\ homogenously\\:\\ 0\\.05013858974719908\ \(0\)\
\-\ strongly\\:\\ 0\\.036023298586515755\ \(0\)\
\-\ hyperdenities\\:\\ 0\\.03339211524229734\ \(0\)\
\-\ dural\\:\\ 0\\.03138401204170145\ \(0\)\
\-\ 88\\-year\\:\\ 0\\.030766557740176337\ \(0\)\
\-\ caregiver\\:\\ 0\\.030766557740176337\ \(0\)\
\-\ 2\\:1\\.\\:\\ 0\\.030766557740176337\ \(0\)\
\-\ nonglial\\:\\ 0\\.030766557740176337\ \(0\)\
\-\ one\\-day\\:\\ 0\\.02923070505794844\ \(0\)\
\-\ brain\\:\\ 0\\.02921990367389502\ \(0\)\
\-\ variably\\:\\ 0\\.028141000238055332\ \(0\)\
\-\ demontrate\\:\\ 0\\.028141000238055332\ \(0\)\
\-\ stippled\\:\\ 0\\.027295759513380296\ \(0\)\
\-\ exceedingly\\:\\ 0\\.026605147555827435\ \(0\)\
\-\ grey\\-white\\:\\ 0\\.02602124346557267\ \(0\)\
\-\ 40\\-60\\:\\ 0\\.02602124346557267\ \(0\)\
\-\ this\\:\\ 0\\.025484698837874742\ \(0\)\
\-\ meningioma\\:\\ 0\\.02489461618526572\ \(0\)\
\-\ incidental\\:\\ 0\\.02451354998469906\ \(0\)\
\-\ calcification\\:\\ 0\\.023498375897402494\ \(0\)\
\-\ slurred\\:\\ 0\\.023395685963451665\ \(0\)\
\-\ adherent\\:\\ 0\\.02288988523381332\ \(0\)\
\-\ unremarkable\\:\\ 0\\.021432321353651976\ \(0\)\
\-\ symptomatology\\:\\ 0\\.02090788468925064\ \(0\)\
\-\ finding\\:\\ 0\\.020864102310897588\ \(0\)\
\-\ falx\\:\\ 0\\.02063720679537888\ \(0\)\
\-\ isodense\\:\\ 0\\.02050879182691039\ \(0\)\
\-\ post\\:\\ 0\\.020385113886911315\ \(0\)\
\-\ preservation\\:\\ 0\\.019924887736655624\ \(0\)\
\-\ imaged\\:\\ 0\\.019924887736655624\ \(0\)\
\-\ elderly\\:\\ 0\\.019058063598667564\ \(0\)\
\-\ evaluation\\:\\ 0\\.018804839362324303\ \(0\)\
\-\ speech\\:\\ 0\\.018650371688848\ \(0\)\
\-\ changes\\:\\ 0\\.01855339375935652\ \(0\)\
\-\ peak\\:\\ 0\\.01842528297494345\ \(0\)\
\-\ itself\\:\\ 0\\.018212822873992528\ \(0\)\
\-\ ratio\\:\\ 0\\.017946897651745373\ \(0\)\
\-\ an\\:\\ 0\\.01790401309522318\ \(0\)\
\-\ contain\\:\\ 0\\.017883234324789388\ \(0\)\
\-\ tail\\:\\ 0\\.01782062333254995\ \(0\)\
\-\ centrally\\:\\ 0\\.01763877022957131\ \(0\)\
\-\ male\\:\\ 0\\.017559153839630377\ \(0\)\
\-\ unless\\:\\ 0\\.017522210916439667\ \(0\)\
\-\ differentiation\\:\\ 0\\.017245600556534783\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.017245600556534783\ \(0\)\
\-\ stroke\\:\\ 0\\.016889430292715557\ \(0\)\
\-\ remaining\\:\\ 0\\.01684117640719499\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.016654082637007198\ \(0\)\
\-\ hyperdense\\:\\ 0\\.016182665309456418\ \(0\)\
\-\ alert\\:\\ 0\\.016142581561992265\ \(0\)\
\-\ rounded\\:\\ 0\\.015948288780221236\ \(0\)\
\-\ oriented\\:\\ 0\\.015873278828341768\ \(0\)\
\-\ times\\:\\ 0\\.015692006020850725\ \(0\)\
\-\ enhance\\:\\ 0\\.01565676968500863\ \(0\)\
\-\ represents\\:\\ 0\\.015552985691871836\ \(0\)\
\-\ enhances\\:\\ 0\\.015289374738087003\ \(0\)\
\-\ or\\:\\ 0\\.01517458710551072\ \(0\)\
\-\ work\\:\\ 0\\.015164144199220003\ \(0\)\
\-\ predominantly\\:\\ 0\\.015164144199220003\ \(0\)\
\-\ mental\\:\\ 0\\.015103048055546202\ \(0\)\
\-\ tumor\\:\\ 0\\.015092668951597055\ \(0\)\
\-\ was\\:\\ 0\\.014973901851722527\ \(0\)\
\-\ incidence\\:\\ 0\\.014839691757634799\ \(0\)\
\-\ dermoid\\:\\ 0\\.014755823856584747\ \(0\)\
\-\ reaction\\:\\ 0\\.014700926101650783\ \(0\)\
\-\ contrast\\:\\ 0\\.01449072490005989\ \(0\)\
\-\ necessary\\:\\ 0\\.014337426146113873\ \(0\)\
\-\ per\\:\\ 0\\.01416797200277527\ \(0\)\
\-\ case\\:\\ 0\\.014162912370206598\ \(0\)\
\-\ demonstrates\\:\\ 0\\.014141069709493834\ \(0\)\
\-\ 60\\:\\ 0\\.014120917002780736\ \(0\)\
\-\ either\\:\\ 0\\.014097606905908092\ \(0\)\
\-\ room\\:\\ 0\\.013916116922211508\ \(0\)\
\-\ calcified\\:\\ 0\\.013894030102852443\ \(0\)\
\-\ underlying\\:\\ 0\\.013872071323745148\ \(0\)\
\-\ suggest\\:\\ 0\\.013785487467396475\ \(0\)\
\-\ intracranial\\:\\ 0\\.013679968700339783\ \(0\)\
\-\ mass\\:\\ 0\\.013505238715313233\ \(0\)\
\-\ administration\\:\\ 0\\.01343810706402716\ \(0\)\
\-\ specific\\:\\ 0\\.013379979906168599\ \(0\)\
\-\ are\\:\\ 0\\.013237203096927292\ \(0\)\
\-\ patient\\:\\ 0\\.012978665619945273\ \(0\)\
\-\ matter\\:\\ 0\\.012744242312124234\ \(0\)\
\-\ rare\\:\\ 0\\.01256950832830794\ \(0\)\
\-\ images\\:\\ 0\\.012418665848101168\ \(0\)\
\-\ emergency\\:\\ 0\\.01225677499234953\ \(0\)\
\-\ tumors\\:\\ 0\\.012158016506327656\ \(0\)\
\-\ throughout\\:\\ 0\\.01211646714507548\ \(0\)\
\-\ appears\\:\\ 0\\.012048215230292609\ \(0\)\
\-\ weakness\\:\\ 0\\.012021255125107518\ \(0\)\
\-\ laboratory\\:\\ 0\\.011928377787326009\ \(0\)\
\-\ malignant\\:\\ 0\\.011699510137800384\ \(0\)\
\-\ did\\:\\ 0\\.011687191821942894\ \(0\)\
\-\ they\\:\\ 0\\.011662674721542827\ \(0\)\
\-\ status\\:\\ 0\\.011554270155991113\ \(0\)\
\-\ typically\\:\\ 0\\.011425855187522623\ \(0\)\
\-\ being\\:\\ 0\\.011279499912123328\ \(0\)\
\-\ benign\\:\\ 0\\.011170645329671217\ \(0\)\
\-\ on\\:\\ 0\\.010968045641900426\ \(0\)\
\-\ masses\\:\\ 0\\.0109416378711973\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.010773699182484983\ \(0\)\
\-\ central\\:\\ 0\\.010650118775984693\ \(0\)\
\-\ follow\\:\\ 0\\.010284846484645584\ \(0\)\
\-\ will\\:\\ 0\\.010126822039314932\ \(0\)\
\-\ age\\:\\ 0\\.009851933051304192\ \(0\)\
\-\ some\\:\\ 0\\.009829273688889239\ \(0\)\
\-\ years\\:\\ 0\\.009504708852342737\ \(0\)\
\-\ demonstrated\\:\\ 0\\.009497802963852149\ \(0\)\
\-\ not\\:\\ 0\\.009354686907135874\ \(0\)\
\-\ two\\:\\ 0\\.00927019408187881\ \(0\)\
\-\ axial\\:\\ 0\\.009237846500257088\ \(0\)\
\-\ \\,\\:\\ 0\\.009228752233543887\ \(0\)\
\-\ through\\:\\ 0\\.009193019009169957\ \(0\)\
\-\ ct\\:\\ 0\\.009055330707515477\ \(0\)\
\-\ however\\:\\ 0\\.00901275778635254\ \(0\)\
\-\ up\\:\\ 0\\.008703966481265998\ \(0\)\
\-\ is\\:\\ 0\\.008519557248253418\ \(0\)\
\-\ common\\:\\ 0\\.008470709136198474\ \(0\)\
\-\ who\\:\\ 0\\.008439274277051902\ \(0\)\
\-\ these\\:\\ 0\\.00842365413620394\ \(0\)\
\-\ patients\\:\\ 0\\.008377176512750098\ \(0\)\
\-\ anterior\\:\\ 0\\.008336336453646733\ \(0\)\
\-\ to\\:\\ 0\\.008088411144753527\ \(0\)\
\-\ acute\\:\\ 0\\.00799196715570642\ \(0\)\
\-\ physical\\:\\ 0\\.007941307839322873\ \(0\)\
\-\ soft\\:\\ 0\\.007882298348460416\ \(0\)\
\-\ tissue\\:\\ 0\\.007672049956259825\ \(0\)\
\-\ imaging\\:\\ 0\\.007583612971422737\ \(0\)\
\-\ \\%\\:\\ 0\\.007550458459643968\ \(0\)\
\-\ most\\:\\ 0\\.007472860385333621\ \(0\)\
\-\ mri\\:\\ 0\\.007436650965585681\ \(0\)\
\-\ were\\:\\ 0\\.007349569457158793\ \(0\)\
\-\ can\\:\\ 0\\.007341751335110112\ \(0\)\
\-\ exam\\:\\ 0\\.007110734621020978\ \(0\)\
\-\ have\\:\\ 0\\.0070092351453223175\ \(0\)\
\-\ female\\:\\ 0\\.006654394967605431\ \(0\)\
\-\ presents\\:\\ 0\\.006612288998136083\ \(0\)\
\-\ treatment\\:\\ 0\\.006551579392427603\ \(0\)\
\-\ no\\:\\ 0\\.006518516293210621\ \(0\)\
\-\ seen\\:\\ 0\\.006396316723741251\ \(0\)\
\-\ which\\:\\ 0\\.006042214345615715\ \(0\)\
\-\ for\\:\\ 0\\.00552354658062663\ \(0\)\
\-\ the\\:\\ 0\\.005236715329682795\ \(0\)\
\-\ be\\:\\ 0\\.004991502739939126\ \(0\)\
\-\ as\\:\\ 0\\.004896126916265636\ \(0\)\
\-\ in\\:\\ 0\\.004788604887957443\ \(0\)\
\-\ a\\:\\ 0\\.004506815929756833\ \(0\)\
\-\ history\\:\\ 0\\.0044705096125268315\ \(0\)\
\-\ right\\:\\ 0\\.003415271625418245\ \(0\)\
\-\ old\\:\\ 0\\.003314146200235813\ \(0\)\
\-\ \\.\\:\\ 0\\.0025548908554908307\ \(0\)\
\-\ with\\:\\ 0\\.002215988183520639\ \(0\)\
\-\ of\\:\\ 0\\.002206511378749781\ \(0\)\
\-\ and\\:\\ 0\\.0020455568833206645\ \(0\)\
